The Anti-BCMA (Belantamab) Biosimilar Monoclonal Antibody (HDbs0028) offered by Assay Genie is a cutting-edge product designed for research involving BCMA, a cell surface protein known for its role in multiple myeloma. This antibody is specifically designed to target BCMA, allowing for accurate detection and analysis in various cell types.BCMA, also known as B cell maturation antigen, is a promising target for the treatment of multiple myeloma, a type of blood cancer that affects plasma cells. Belantamab mafodotin, a BCMA-targeted therapy, has shown promising results in clinical trials, making it a valuable tool for researchers studying this protein in the context of cancer treatment.
This biosimilar monoclonal antibody is highly reactive with human samples and has been validated for use in a variety of applications, including Western blotting. Its unique ability to bind to BCMA makes it an essential tool for researchers in the field of oncology and immunology, providing valuable insights into the mechanisms of BCMA signaling and its potential as a therapeutic target.Overall, the Anti-BCMA (Belantamab) Biosimilar Monoclonal Antibody (HDbs0028) from Assay Genie is a valuable resource for researchers seeking to advance their understanding of BCMA and its role in cancer biology, offering high specificity and sensitivity for accurate and reliable results.
Product Name:
Belantamab (Anti-BCMA) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0028
Target:
BCMA
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
2857916, GSK2857916, J6M0, J6M0-mcMMAF
Description:
Anti-BCMA ( belantamab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
